75
Participants
Start Date
July 28, 2021
Primary Completion Date
June 30, 2026
Study Completion Date
March 31, 2027
Oxytocin nasal spray
24 IU nasal spray, 4 times per day for 12 weeks
Placebo
24 IU nasal spray, 4 times per day for 12 weeks
RECRUITING
Massachusetts General Hospital, Boston
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Massachusetts General Hospital
OTHER